Treatment with ambroxol hydrochloride significantly increased glucosylceramidase activity in fibroblasts from healthy controls, Gaucher disease patients, and heterozygous glucocerebrosidase mutation carriers with PD. This evidence concerns the gene GBA1 and Gaucher disease.